诚意药业：控股股东之一致行动人拟减持不超1.18%股份

Group 1 - The core point of the article is that Chengyi Pharmaceutical (603811.SH) announced a plan for share reduction by its controlling shareholder and related parties, which may impact the company's stock performance [1] - The controlling shareholder Yan Yiyi and a related party plan to reduce their holdings by up to 3,875,622 shares, representing 1.18% of the total share capital [1] - The reasons for the share reduction include compliance with the regulatory requirements from the National Financial Regulatory Administration and personal funding needs [1]